Annex

Annex I to Decision 2000/96/EC is replaced by the following:

ANNEX I

1.

COMMUNICABLE DISEASES AND SPECIAL HEALTH ISSUES TO BE PROGRESSIVELY COVERED BY THE COMMUNITY NETWORK AS REFERRED TO IN ARTICLE 1

1.1.

For the communicable diseases and special health issues listed in this Annex, epidemiological surveillance within the Community network is to be performed by the standardised collection and analysis of data in a way that is to be determined for each communicable disease and special health issue when specific surveillance networks are put in place.

2.

DISEASES

2.1.

Diseases preventable by vaccination

Diphtheria

Infections with Haemophilus influenza group B

Influenza

Measles

Mumps

Pertussis

Poliomyelitis

Rubella

Smallpox

Tetanus

2.2.

Sexually-transmitted diseases

Chlamydia infections

Gonococcal infections

HIV infection

Syphilis

2.3.

Viral hepatitis

Hepatitis A

Hepatitis B

Hepatitis C

2.4.

Food- and waterborne diseases and diseases of environmental origin

Anthrax

Botulism

Campylobacteriosis

Cryptosporidiosis

Giardiasis

Infection with Enterohaemorrhagic E. coli

Leptospirosis

Listeriosis

Salmonellosis

Shigellosis

Toxoplasmosis

Trichinosis

Yersinosis

2.5.

Other diseases

2.5.1.

Diseases transmitted by non-conventional agents

Transmissible spongiform encephalopathies, variant Creutzfeldt-Jakob’s disease

2.5.2.

Airborne diseases

Legionellosis

Meningococcal disease

Pneumococcal infections

Tuberculosis

Severe acute respiratory syndrome (SARS)

2.5.3.

Zoonoses (other than those listed in 2.4)

Brucellosis

Echinococcosis

Rabies

Q fever

Tularaemia

Avian influenza in humans

West Nile virus infection

2.5.4.

Serious imported diseases

Cholera

Malaria

Plague

Viral haemorrhagic fevers

3.

SPECIAL HEALTH ISSUES

3.1.

Nosocomial infections

3.2.

Antimicrobial resistance